- Investing Ideas
- Danish Pharmaceuticals & Biotech High Insider Buying
Danish Pharmaceuticals & Biotech High Insider Buying
Results
4
Stocks with high levels of insider buying the past 3 months and good analyst coverage.
4 companies
H. Lundbeck
Market Cap: DKK 36.3b
Engages in the research, development, manufacturing, and commercializing pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, United States, and internationally.
HLUN B
DKK 37.48
7D
-0.4%
1Y
-5.4%
Bavarian Nordic
Market Cap: DKK 14.7b
Develops, manufactures, and supplies life-saving vaccines.
BAVA
DKK 190.30
7D
3.8%
1Y
18.6%
ChemoMetec
Market Cap: DKK 6.9b
Engages in the development, production, and sale of analytical equipment for cell counting and analysis the United States, Canada, Europe, and internationally.
CHEMM
DKK 398.60
7D
-0.4%
1Y
-24.1%
Gubra
Market Cap: DKK 6.2b
A disease-agnostic techbio company, focuses on the peptide-based drug discovery and preclinical contract research services in Europe, North America, and internationally.
GUBRA
DKK 378.40
7D
-0.2%
1Y
-20.5%